BioMed X launches Harvard pilot to connect academia and pharma
Projects selected for advancement will move forward through the Harvard Office of Technology Development’s processes for sponsored research agreements
Projects selected for advancement will move forward through the Harvard Office of Technology Development’s processes for sponsored research agreements
The primary goal of the collaboration is joint research into trending and next-generation molecules
Growing patent filings and tier-2 innovators reflect expanding national research base
The discussion at the fourth session was centered on the fusion of academic rigor and industrial pragmatism as a key to pioneering solutions for sustainable and prosperous future
The next phase of growth in pharma depends on the industry-oriented workforce, risk investment, academic revamp, and creation of R&D hubs, say experts .
The approved scheme will deliver around 1 million sq ft of state-of-the-art laboratory and research space across a 12-acre site
The Union Budget 2026–27 accords strong priority to the upgradation and expansion of healthcare infrastructure and medical education
The injectable borofalan (10B), developed by CNNC Headway—a subsidiary of China Isotope & Radiation Corporation (CIRC) under the China National Nuclear Corporation (CNNC)—has officially entered Phase I clinical trials
India in the Changing Landscape of Life-Sciences Research & Development
Subscribe To Our Newsletter & Stay Updated